Explore

Capbase

Pierogi Therapeutics, Inc — Funding, Investors & Profile — Capbase

Private

Private securities offering disclosed via SEC Form D.

Biotechnology

$50KSource: [SEC]Total raised

UndisclosedSource: [SEC]Last valuation

Pierogi Therapeutics, Inc filed a Form D notice of exempt offering with the SEC.

1 rounds

No investors recorded yet for Pierogi Therapeutics, Inc.

Leadership

Samuel Benjamin KobyExecutive Officer · Koby serves as CEO and a member of the Board of Directors.Since 2026Source: [SEC]

Filipp GusevExecutive Officer · Gusev serves as CSO and member of the Board of Directors.Since 2026Source: [SEC]

Pierogi Therapeutics, Inc has no recorded acquisitions.

Still private — no exit on record.

No diversity signals recorded yet for Pierogi Therapeutics, Inc.

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.